Frequency of ABL gene mutations in chronic myeloid leukemia patients resistant to imatinib and results of treatment switch to second-generation tyrosine kinase inhibitorsSílvia Marcé, Fuensanta Millá, Javier Grau et al.|Medicina Clínica|2013Cited by 11
Role of ABL Gene Mutations in Chronic Myeloid Leukemia Patients Resistant to Imatinib and Results of Treatment Shift to Second-Generation Tyrosine Kinase InhibitorsSílvia Marcé, Fuensanta Millá, Lurdes Zamora et al.|Blood|2011Cited by 0
Clinical and Biological Characteristics According to the Burden of JAK2V617F Mutated Allele in BCR-ABL Negative MPNsLurdes Zamora, Fuensanta Millá, Marta Cabezón et al.|Blood|2012Cited by 0